Pilot Trial of E Cigarettes in Pts Diagnosed With Cancer of the Head, Neck, and Lung (NCT05412875) | Clinical Trial Compass
WithdrawnNot Applicable
Pilot Trial of E Cigarettes in Pts Diagnosed With Cancer of the Head, Neck, and Lung
Stopped: Funding lapse
United States0Started 2024-01-01
Plain-language summary
This clinical trial investigates the acceptability of electronic cigarettes (JUUL) for smoking cessation (quitting smoking) and the reduction of surgery-related complications in patients with newly diagnosed head, neck, or lung cancer. Smoking before surgery is associated with increased risk of complications during and after surgery. Electronic cigarettes are a type of special product that gives small, steady doses of nicotine to help stop cravings and relieve symptoms that occur when a person is trying to quit smoking. Stopping cigarette smoking before surgery may reduce the risk of complications during and after surgery in patients with head, neck, or lung cancer.
Who can participate
Age range
21 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Newly diagnosed lung cancer subjects will be stages I-III non-small cell lung cancer (NSCLC) and head and neck cancer subjects will be stages I-IV squamous cell carcinoma (SCC).
* Current smokers of combustible cigarettes who smoke \>= 4 days/week.
* Lung cancer patients planning to undergo wedge resection surgery for their index cancer.
* Head and neck cancer patients planning to undergo surgical resection of their index cancer or exploratory biopsies (tonsil cancer).
* Patients must intend to receive ongoing oncology care at Ohio State University \[OSU\] (i.e., their clinic visit is not a consultation/second opinion).
* Patients that are over the age of 21 years.
Exclusion Criteria:
* Patients who are cognitively unable to understand the consent form or participate in interviews.
* Patients with hearing impairments.
* Patients who are planning to use or are currently using cessation medication to help quit or reduce smoking.
* Patients who are currently using e-cigarettes.
* Patients undergoing surgery including lobectomy, pneumonectomy, tracheotomy, laryngectomy, or free flap surgery.
* Patients with contraindications to per oral intake.
* Lung cancer patients who are on home supplemental oxygen at baseline.
* Patients that have problems with dexterity that would impact electronic cigarette use.
* Patients under 21 years of age.
* Patients who don't speak and read English.
* Patients with histologies other than NSCLC, or squamous cell carcinoma of …
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Feasibility of patients measured by number of screened per month
Timeframe: Up to 6 months
2
Feasibility of patients measured by number of screened per month by eligibility status
Timeframe: Up to 6 months
3
Feasibility of patients measured by number of screened per month by refusal status
Timeframe: Up to 6 months
4
Reasons for participant ineligibility
Timeframe: Baseline
5
Reasons for participant refusal
Timeframe: Baseline
6
Acceptance measured by participation rate
Timeframe: Up to 6 months
7
Compliance
Timeframe: Up to 6 months
8
Trial details
NCT IDNCT05412875
SponsorOhio State University Comprehensive Cancer Center